Photo/NBD

July 2 (NBD) -- Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharmaceutical", 600196.SH) is to launch several new drugs including the blockbuster rituximab, the pharmaceutical company's Chairman and CEO Wu Yifang said at an event held by the business news portal Securities Times.

Several drugs of Fosun Pharmaceutical have passed the quality and efficacy consistency evaluation year to date, and those drugs will help push the company's market growth, Wu further noted.

Wu added that global deployments the company had made over the past several years are ready to take off and the company's overseas businesses are growing at a faster speed than its domestic ones in 3 years.

Email: gaohan@nbd.com.cn